S. Sisakhtnezhad and L. Khosravi, Emerging physiological and pathological implications of tunneling nanotubes formation between cells, Eur J Cell Biol, vol.94, issue.10, pp.429-472, 2015.

K. Mccoy-simandle, S. J. Hanna, and D. Cox, Exosomes and nanotubes: Control of immune cell communication, Int J Biochem Cell Biol, vol.71, pp.44-54, 2016.

L. A. Torre, R. L. Siegel, and A. Jemal, Lung Cancer Statistics, Adv Exp Med Biol, vol.893, pp.1-19, 2016.

M. Malvezzi, P. Bertuccio, T. Rosso, M. Rota, F. Levi et al., European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?, Ann Oncol, vol.26, issue.4, pp.779-86, 2015.

D. Sharma, T. G. Newman, and W. S. Aronow, Lung cancer screening: history, current perspectives, and future directions, Arch Med Sci AMS, vol.11, issue.5, pp.1033-1076, 2015.

B. Knight, S. Crosbie, P. A. Balata, H. Chudziak, J. Hussell et al., Progress and prospects of early detection in lung cancer, Open Biol, vol.7, issue.9, 2017.

B. Davidson, S. Nielsen, J. Christensen, P. Asschenfeldt, A. Berner et al., The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells, Am J Surg Pathol, vol.25, issue.11, pp.1405-1417, 2001.

L. Stang, N. Belot, A. , G. Soit-ilg, A. Rolland et al., Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and, Int J Cancer, vol.126, issue.1, pp.232-240, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00698003

J. Peto, A. Decarli, L. Vecchia, C. Levi, F. Negri et al., The European mesothelioma epidemic, Br J Cancer, vol.79, issue.3-4, pp.666-72, 1999.

A. Scherpereel, Malignant pleural mesothelioma: new treatments, new hopes?, Eur Respir J, vol.49, issue.3, p.1700319, 2017.

G. Ak, Y. Tada, H. Shimada, S. Metintas, M. Ito et al., Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin, BMC Cancer, vol.17, 2017.

F. Galateau-salle, A. Churg, V. Roggli, and W. D. Travis, World Health Organization Committee for Tumors of the Pleura. The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer, vol.11, issue.2, pp.142-54, 2016.

G. Zalcman, J. Mazieres, J. Margery, L. Greillier, C. Audigier-valette et al., Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial, Lancet Lond Engl, vol.387, pp.1405-1419, 2016.

J. W. Ady, S. Desir, V. Thayanithy, R. I. Vogel, A. L. Moreira et al., Intercellular communication in malignant pleural mesothelioma: properties of tunneling nanotubes, Front Physiol, vol.5, p.400, 2014.

A. Destro, G. L. Ceresoli, E. Baryshnikova, I. Garassino, P. A. Zucali et al., Gene methylation in pleural mesothelioma: correlations with clinicopathological features and patient's follow-up, Lung Cancer Amst Neth, 2008.

, L'étude des TnTs n'en est qu'à ses balbutiements et le nombre croissant de publication sur le sujet laisse présager pour ce domaine d'étude novateur de nombreuses applications que ce soit dans les thérapies de lutte contre le cancer mais également contre les maladies infectieuses

, En effet, les TnTs pourrait jouer un rôle dans la sauvegarde/restauration cellulaire via le transfert de mitochondrie dans un contexte de dommage cellulaire ischémique lié à un d'infarctus

. Références,

L. B. Hesson, W. N. Cooper, and F. Latif, The Role of RASSF1A Methylation in Cancer, Dis Markers, vol.23, issue.1-2, pp.73-87, 2007.

A. Agathanggelou, S. Honorio, D. P. Macartney, A. Martinez, A. Dallol et al., Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours, Oncogene, vol.20, issue.12, pp.1509-1527, 2001.

I. I. Wistuba, C. Behrens, A. K. Virmani, G. Mele, S. Milchgrub et al., High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints, Cancer Res, vol.60, issue.7, pp.1949-60, 2000.

D. Kim, J. S. Kim, Y. Ji, Y. M. Shim, H. Kim et al., Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer, Cancer Res, vol.63, issue.13, pp.3743-3749, 2003.

D. Bräuer-hartmann, J. Hartmann, A. A. Wurm, D. Gerloff, C. Katzerke et al., PML/RAR?-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia, Cancer Res, vol.75, issue.16, pp.3411-3435, 2015.

Z. He, X. Wang, C. Huang, Y. Gao, C. Yang et al., The FENDRR/miR-214-3P/TET2 axis affects cell malignant activity via RASSF1A methylation in gastric cancer, Am J Transl Res, vol.10, issue.10, pp.3211-3234, 2018.

L. Yang, Z. Ma, D. Wang, W. Zhao, L. Chen et al., MicroRNA-602 regulating tumor suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular carcinoma, Cancer Biol Ther, vol.9, issue.10, pp.803-811, 2010.

A. M. Grawenda and E. O'neill, Clinical utility of RASSF1A methylation in human malignancies, Br J Cancer, vol.113, issue.3, pp.372-81, 2015.

F. De-fraipont, G. Levallet, C. Creveuil, E. Bergot, M. Beau-faller et al., An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial, Clin Cancer Res Off J Am Assoc Cancer Res, vol.18, issue.10, pp.2976-86, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00718845

J. R. Fischer, U. Ohnmacht, N. Rieger, M. Zemaitis, C. Stoffregen et al., Prognostic significance of RASSF1A promoter methylation on survival of nonsmall cell lung cancer patients treated with gemcitabine. Lung Cancer Amst Neth, vol.56, pp.115-138, 2007.

W. M. Szejniuk, A. I. Robles, T. Mcculloch, U. Falkmer, and O. D. Røe, Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art, Pharmacogenomics J, vol.19, issue.1, pp.5-14, 2019.

B. Knight, S. Crosbie, P. A. Balata, H. Chudziak, J. Hussell et al., Reduced lung-cancer mortality with low-dose computed tomographic screening, N Engl J Med, vol.7, issue.9, pp.395-409, 2011.

B. Wang, Y. Li, J. Han, L. Zhou, Y. Lv et al., Gene methylation as a powerful biomarker for detection and screening of non-small cell lung cancer in blood, Oncotarget, vol.8, issue.19, pp.31692-704, 2017.

M. Majem, O. Juan, A. Insa, N. Reguart, J. M. Trigo et al., SEOM clinical guidelines for the treatment of non-small cell lung cancer, Clin Transl Oncol, vol.21, issue.1, pp.3-17, 2018.

M. V. Brock, C. M. Hooker, E. Ota-machida, Y. Han, M. Guo et al., DNA methylation markers and early recurrence in stage I lung cancer, N Engl J Med, vol.358, issue.11, pp.1118-1146, 2008.

H. Chen, M. Suzuki, Y. Nakamura, M. Ohira, S. Ando et al., Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer, Oncol Rep, vol.15, issue.5, pp.1281-1286, 2006.

W. Niklinska, W. Naumnik, A. Sulewska, M. Koz?owski, W. Pankiewicz et al., Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC), Folia Histochem Cytobiol, vol.47, issue.2, pp.275-80, 2009.

A. M. Safar, H. Spencer, X. Su, M. Coffey, C. A. Cooney et al., Methylation profiling of archived non-small cell lung cancer: a promising prognostic system, Clin Cancer Res Off J Am Assoc Cancer Res, vol.11, issue.12, pp.4400-4405, 2005.

V. Quillien, A. Lavenu, L. Karayan-tapon, C. Carpentier, M. Labussière et al., Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNAmethyltranferase in a series of 100 glioblastoma patients, Cancer, vol.118, issue.17, pp.4201-4212, 2012.

T. Ye and H. Chen, Adjuvant targeted therapy for resected NSCLC: to be or not to be?, J Thorac Dis, vol.10, pp.3297-3306, 2018.

M. Santarpia, A. Liguori, D. 'aveni, A. Karachaliou, N. Gonzalez-cao et al., Liquid biopsy for lung cancer early detection, J Thorac Dis, vol.10, issue.7, pp.882-97, 2018.

L. Wei, M. Surma, S. Shi, N. Lambert-cheatham, and J. Shi, Novel Insights into the Roles of Rho Kinase in Cancer, Arch Immunol Ther Exp (Warsz), vol.64, pp.259-78, 2016.

R. Abylkassov and Y. Xie, Role of Yes-associated protein in cancer: An update, Oncol Lett, vol.12, issue.4, pp.2277-82, 2016.

F. Zanconato, M. Cordenonsi, and S. Piccolo, YAP/TAZ at the Roots of Cancer, Cancer Cell, vol.13, issue.6, pp.783-803, 2016.

F. Dubois, J. , B. Roberge, H. Bénard, M. Galas et al., A role for RASSF1A in tunneling nanotube formation between cells through GEFH1/Rab11 pathway control, Cell Commun Signal CCS, vol.16, issue.1, p.66, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02010920

F. Dubois, M. Keller, O. Calvayrac, F. Soncin, L. Hoa et al., RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway, Cancer Res, vol.76, issue.6, pp.1627-1667, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02037182

J. Skog, T. Wurdinger, S. Van-rijn, D. Meijer, L. Gainche et al., Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers, Nat Cell Biol, vol.10, issue.12, pp.1470-1476, 2008.

Y. Zhang and X. Wang, A niche role for cancer exosomes in metastasis, Nat Cell Biol, vol.17, issue.6, pp.709-720, 2015.

K. Mccoy-simandle, S. J. Hanna, and D. Cox, Exosomes and nanotubes: Control of immune cell communication, Int J Biochem Cell Biol, vol.71, pp.44-54, 2016.

Y. Hekmatshoar, J. Nakhle, M. Galloni, and M. Vignais, The role of metabolism and tunneling nanotube-mediated intercellular mitochondria exchange in cancer drug resistance, Biochem J, vol.475, issue.14, pp.2305-2333, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01855869

M. Vignais, A. Caicedo, J. Brondello, and C. Jorgensen, Cell Connections by Tunneling Nanotubes: Effects of Mitochondrial Trafficking on Target Cell Metabolism, Homeostasis, and Response to Therapy, Stem Cells Int, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01759757

S. Desir, P. Wong, T. Turbyville, D. Chen, M. Shetty et al., Intercellular Transfer of Oncogenic KRAS via Tunneling Nanotubes Introduces Intracellular Mutational Heterogeneity in Colon Cancer Cells, Cancers, vol.11, issue.7, 2019.

S. Sisakhtnezhad and L. Khosravi, Emerging physiological and pathological implications of tunneling nanotubes formation between cells, Eur J Cell Biol, vol.94, issue.10, pp.429-472, 2015.

M. Panasiuk, M. Rych?owski, N. Derewo?ko, and K. Bie?kowska-szewczyk, Tunneling Nanotubes as a Novel Route of Cell-to-Cell Spread of Herpesviruses, J Virol, vol.92, issue.10, 201815.

E. Lou, S. Gholami, Y. Romin, V. Thayanithy, S. Fujisawa et al., Imaging Tunneling Membrane Tubes Elucidates Cell Communication in Tumors. Trends Cancer, vol.3, pp.678-85, 2017.

T. M. Ribeiro-rodrigues, T. Martins-marques, S. Morel, B. R. Kwak, and H. Girão, Role of connexin 43 in different forms of intercellular communication -gap junctions, extracellular vesicles and tunnelling nanotubes, J Cell Sci, vol.130, issue.21, pp.3619-3649, 2017.

M. Dauphin, C. Barbe, S. Lemaire, B. Nawrocki-raby, E. Lagonotte et al., Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas, Lung Cancer Amst Neth, vol.81, issue.1, pp.117-139, 2013.

H. Xu, Q. Li, Y. Zhang, Y. Zhao, Y. Liu et al., Connexin 43 recruits E-cadherin expression and inhibits the malignant behaviour of lung cancer cells, Folia Histochem Cytobiol, vol.46, issue.3, pp.315-336, 2008.

N. Genet, N. Bhatt, A. Bourdieu, and K. K. Hirschi, Multifaceted Roles of Connexin 43 in Stem Cell Niches, Curr Stem Cell Rep, vol.4, issue.1, pp.1-12, 2018.

R. Mittal, E. Karhu, J. Wang, S. Delgado, R. Zukerman et al., Cell communication by tunneling nanotubes: Implications in disease and therapeutic applications, J Cell Physiol, vol.234, issue.2, pp.1130-1176, 2019.

J. Wang, X. Liu, Y. Qiu, Y. Shi, J. Cai et al., Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells, J Hematol OncolJ Hematol Oncol [Internet], vol.11, 2018.

R. Moschoi, V. Imbert, M. Nebout, J. Chiche, D. Mary et al., Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy, Blood, vol.128, issue.2, pp.253-64, 2016.

K. Suganuma, H. Miwa, N. Imai, M. Shikami, M. Gotou et al., Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation, Leuk Lymphoma, vol.51, issue.11, pp.2112-2121, 2010.

I. Sáenz-de-santa-maría, C. Bernardo-castiñeira, E. Enciso, I. García-moreno, J. L. Chiara et al., Control of long-distance cell-to-cell communication and autophagosome transfer in squamous cell carcinoma via tunneling nanotubes, Oncotarget, vol.8, issue.13, pp.20939-60, 2017.

J. Whitehead, J. Zhang, J. N. Harvestine, A. Kothambawala, G. Liu et al., Tunneling Nanotubes Mediate the Expression of Senescence Markers in

, Mesenchymal Stem/Stromal Cell Spheroids. Stem Cells Dayt Ohio, 2019.

H. Hu, C. Zhou, B. Li, Y. Chen, J. Dai et al., Diagnostic value of RASSF1A hypermethylation in colorectal cancer: a meta-analysis, Pathol Res Pract, vol.214, issue.10, pp.1572-1580, 2018.